계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
PNP Therapeutics
company
About
PNP Therapeutics is engaged in the development of technology and proprietary products for the treatment of cancer.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $0.92M
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2000
- Number Of Employee
- 1 - 10
- Operating Status
- Active
PNP Therapeutics is an early-stage, biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer. At the center of PNP's Therapeutic System is a patented enzyme (E. coli purine nucleoside phosphorylase) that has been shown to work with a variety of well-characterized nucleoside prodrugs generating active metabolites with high levels of anti-tumor activity.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$0.92M
PNP Therapeutics has raised a total of
$0.92M
in funding over 2 rounds. Their latest funding was raised on
Jun 7, 2007 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 7, 2007 | Series B | $0.92M | 1 |
Greer Capital Advisors
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
PNP Therapeutics is funded by 1 investors.
Greer Capital Advisors
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Greer Capital Advisors
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
